New method for preparing epidermal defect treating drug

A technology for preparing drugs and epidermis, which is applied in the field of preparation of drugs for the treatment of epidermal defects, can solve problems that need to be developed, and achieve the effects of promoting cell proliferation, promoting wound epidermal cell proliferation, and accelerating repair and healing

Inactive Publication Date: 2018-05-25
SOUTH CHINA INSTITUDE OF BIOMEDICINE
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] However, current treatments and drugs for skin damage are still to be developed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New method for preparing epidermal defect treating drug
  • New method for preparing epidermal defect treating drug
  • New method for preparing epidermal defect treating drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Example 1 Acquisition and identification of exosomes

[0051] 1. The acquisition of exosomes

[0052] (1) Provide mesenchymal stem cells

[0053] The morphology of umbilical cord mesenchymal stem cells is like figure 1 As shown, the mesenchymal stem cells with good expansion and proliferation status were taken, and the cells were digested into single cells with TrypLE Express digestion enzyme; then washed with PBS containing 1% BSA to prepare the cells containing 5×10 6 A single cell suspension of umbilical cord mesenchymal stem cells, and labeled CD90, CD73, CD105, CD34, CD45, CD14, CD19, HLA-CR flow cytometry antibody (BD Company, USA), each tube added 5μl at room temperature Incubate in light for 20 minutes; after washing twice with PBS containing 1% BSA, resuspend the cells to 400 μl, and perform flow cytometry. The results are as follows figure 2 As shown, (A) to (H) are HLA-CR, CD14, CD19, CD105, CD34, CD45, CD73, CD90 antibodies, respectively. From Table 1, it can be ...

Embodiment 2

[0061] Example 2 Preparation of the second reagent

[0062] (1) Soak the fresh oxtail in 75% alcohol for 10 minutes, and then repeatedly rinse with sterile normal saline;

[0063] (2) Peel off the tail tendon, remove the muscle membrane and fascia, and place it in a sterile dish;

[0064] (3) Cut the tail tendon, immerse it in 0.05mol / L acetic acid solution and shake at 4℃ for 48 hours;

[0065] (4) Move it into a pulverizer to smash, and then put it in a 4℃ refrigerator for secondary expansion;

[0066] (5) After 24 hours, filter with a 200-mesh screen and collect the filtrate to obtain a collagen solution;

[0067] (6) In a 6-well plate, add 5ml of collagen solution to each well to spread it flat in the well;

[0068] (7) Pre-freeze the well plate in a refrigerator at -30°C for 6 hours, and then vacuum dry for 18-24 hours to obtain a collagen sponge;

[0069] (8) Place the collagen sponge in a 10 cm petri dish, and add 30 mL of 0.25% glutaraldehyde solution to the petri dish for pre-cros...

Embodiment 3

[0075] Example 3 Differentiation of mesenchymal stem cells into epidermal cells in vitro

[0076] 1. Differentiation of mesenchymal stem cells into epidermal cells in vitro

[0077] On a 6-well plate pre-covered with Matrigel (BD Company, USA), the planting cell density is 6×10 4 Cells / cm 2 Umbilical cord mesenchymal stem cells, add 2ml low-sugar DMEM medium containing 10% fetal bovine serum to each well at 37℃, 5% CO 2 Cultivate in an incubator until the cells reach 50% fusion, switch to 2ml epidermal induction conditioned medium for induction for 7 days, and change half of the medium every other day.

[0078] Epidermal induction conditioned medium formula: (DMEM:DF12=1:1 (purchased from Sigma), 20ng / ml epidermal growth factor (purchased from R&D), 15ng / ml basic fibroblast growth factor (purchased from R&D), 1% insulin-transferrin-selenium complex (purchased from Sigma), 0.1 μM dexamethasone (purchased from Sigma), 100 U / ml penicillin and 100 μg / ml streptomycin.

[0079] 2. Morpholog...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses uses of a kit in preparation of drugs, wherein the drugs are used for treating epidermal defects, and the kit comprises a first reagent and a second reagent, the first reagentcomprises exosome and cytokine, and the second reagent comprises a biological scaffold and stem cells. According to the present invention, the kit can effectively promote the repair of epidermal damage and the healing of skin wound surfaces.

Description

Technical field [0001] The invention relates to the field of biomedicine. In particular, the present invention relates to a new method for preparing drugs for treating epidermal defects. Background technique [0002] As the largest organ of the human body, the skin has the functions of barrier, protection, and regulation of body temperature and sensation. Skin defects caused by inflammation, ulcers, scalds, burns and other factors can be severely life-threatening. [0003] However, the current treatment methods and drugs for skin damage still need to be developed. Summary of the invention [0004] The present invention aims to solve one of the technical problems existing in the prior art at least to a certain extent. [0005] It should be noted that the present invention was completed based on the inventor's following findings: [0006] At present, autologous skin flaps or skin transplantation are usually used to treat defect wounds in clinical practice, but they are faced with new ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61L27/60A61L27/54A61L27/38A61L27/22A61L27/24
CPCA61L27/60A61L27/227A61L27/24A61L27/3834A61L27/54A61L2300/252A61L2300/414C08L89/00
Inventor 裴雪涛张博文何丽娟岳文裴海云曾泉
Owner SOUTH CHINA INSTITUDE OF BIOMEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap